[1]
Seyyar, M. et al. 2025. Management of Trastuzumab Deruxtecan-Induced Heart Failure and Pneumonitis in a Patient with HER2-Positive Metastatic Breast Cancer: Trastuzumab Deruxtecan-Induced HF and Pneumonia. Avicenna Anatolian Journal of Medicine. 2, 1 (Jun. 2025), 21–24. DOI:https://doi.org/10.5281/zenodo.15570010.